Login / Signup
Patricia N Sidharta
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
Study Protocol
Replacement Therapy
Open Label
Epidermal Growth Factor Receptor
Top Venues
Journal of pharmacokinetics and pharmacodynamics
Clinical and translational science
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Janneke M Brussee
,
Patricia N Sidharta
,
Jasper Dingemanse
,
Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension.
Journal of pharmacokinetics and pharmacodynamics
51 (3) (2024)
Christine Huynh
,
Jasper Dingemanse
,
Henriette E Meyer Zu Schwabedissen
,
Marlene Fonseca
,
Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239.
Clinical and translational science
17 (7) (2024)
Christine Huynh
,
Jasper Dingemanse
,
Henriette E Meyer Zu Schwabedissen
,
Marlene Fonseca
,
Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239.
Clinical and translational science
17 (7) (2024)
Christine Huynh
,
Jasper Dingemanse
,
Henriette E Meyer Zu Schwabedissen
,
Marlene Fonseca
,
Patricia N Sidharta
The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first-in-class ACKR3/CXCR7 antagonist, ACT-1004-1239.
Clinical and translational science
17 (7) (2024)
Janneke M Brussee
,
Patricia N Sidharta
,
Jasper Dingemanse
,
Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension.
Journal of pharmacokinetics and pharmacodynamics
51 (3) (2024)
Janneke M Brussee
,
Patricia N Sidharta
,
Jasper Dingemanse
,
Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension.
Journal of pharmacokinetics and pharmacodynamics
(2024)